about
Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosisBlocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statementLupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritisModeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritisBiomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis.Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries.Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus.Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA studyToll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritisPorphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue.Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8 mg/kg/d) of anakinraMicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritisB cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial.PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis.2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.The human salivary proteome: a critical overview of the results obtained by different proteomic platforms.B cells in systemic sclerosis: a possible target for therapy.Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis.Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritisObesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases).β-Thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up.The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests.Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression.Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review.Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology.EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effectsConsensus statement on the use of rituximab in patients with rheumatoid arthritisThrombogenicity of TNF alpha in rheumatoid arthritis defined through biological probes: TNF alpha blockers.Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequencyPrognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome.TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma.Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid ArthritisPharmacogenetic of antirheumatic treatments: clinical implications.Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission.Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey.Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study
P50
Q24814170-B5C15017-494A-4027-BD64-C171948812DBQ27021115-4EF09C50-8E93-4333-8883-CAB2E8EB21ACQ28218493-DA4CD90C-4B74-42B1-A959-CD9CF2D484FDQ28474817-09C68C88-2100-46E3-B42A-33AA69D0A51CQ31078960-22B43C4E-C716-4DC5-ADC1-476D40348E8AQ33365103-13FBF802-961C-4CF1-9A16-FFB42CBFA46CQ33370573-C3D18D37-DCD9-4FAA-AB68-A46E2DA04EE4Q33540305-F3BD9CF5-0532-4778-BC46-0C442D5C3367Q33740199-9C94DEDE-D0DE-4FA2-BAEA-7D4E70C2B4E4Q33766304-EEA02EBA-70AE-48DB-A595-BAE986ABC3CCQ33817997-1836D0CF-F140-4F9C-8BBC-E6BE9AF568BAQ33849824-4C54CAB5-6EF6-4F23-ACC9-3F1568BEBE77Q33923359-1FC25A2D-3446-46CD-9D93-BC9BA79DAD2EQ34031304-1B3F3839-A274-4B36-A267-66DF67BBAE9EQ34130671-6036BB07-5910-4F54-94AB-D665E67ACC08Q34146881-68C7445F-E71A-4BAD-A885-33E06EA69B0EQ34183002-D8FB1A8A-A3A5-4FC8-B95F-11AD19233BC7Q34208191-21737DC7-B62B-4EBB-8F8A-5412170B2B5EQ34274249-874E9667-B3A0-4175-8BAD-D3E49CC135ADQ34488394-57491E58-AFEA-497C-809B-828151846987Q34607861-1560781F-9E9F-441C-B331-3BDE07AAA55BQ34802740-E631C454-5343-4AD5-A67C-C96E32CD3ABAQ34986829-D63D7C18-8CCF-45CB-84FD-7B6FEA21431DQ35012150-543C1B3C-18B6-43FD-A649-EF59A4A32830Q35018275-57096B9B-666E-4633-B32C-A03610A6D9A6Q35605474-55378F1E-FFD1-408F-988F-BAE84553010BQ35638360-5C2BEAB1-3E5F-4FB3-89A6-B8014AACA08EQ35638615-2D5E540E-08A9-45EB-8205-C201B8D3CE82Q35638676-EFCFA045-E7F1-4865-B3BF-E99240B01F97Q35832290-D591C9EF-9960-4F5F-B7A1-CB2556B97C3BQ35954658-337D0B40-5A95-4FEA-9AA9-87C1683AA9FFQ35996165-68088930-5D2E-4584-8BB2-3CD36C2F6FA1Q36095168-AB466BFF-879E-44B0-B2D0-3BD927BB4314Q36437722-CF6CBFC1-D240-4F6B-B002-6C7073F0F048Q36480014-9EF3746F-5578-42AE-A17E-6E2C01705A6AQ36543127-79A10A89-FECC-4D2E-B1F2-00B274D46676Q36677277-8AD51640-6BA8-4FCB-B3C7-97FEE330CBC3Q36757060-DEFD943E-224F-47AB-94E9-F61451415D14Q36758296-E35AC4AF-C29E-4A1B-B402-4957B6CD04F6Q36876782-4D98CB35-2BED-43DE-ADC3-98D675132F2A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gianfranco Ferraccioli
@ast
Gianfranco Ferraccioli
@en
Gianfranco Ferraccioli
@es
Gianfranco Ferraccioli
@sl
type
label
Gianfranco Ferraccioli
@ast
Gianfranco Ferraccioli
@en
Gianfranco Ferraccioli
@es
Gianfranco Ferraccioli
@sl
prefLabel
Gianfranco Ferraccioli
@ast
Gianfranco Ferraccioli
@en
Gianfranco Ferraccioli
@es
Gianfranco Ferraccioli
@sl
P106
P1153
35432450100
P21
P31
P496
0000-0002-6884-4301